Table 3.
Adverse reactions reported in patients
Adverse event | n (%) |
---|---|
Influenza-like illness | 39 (35.5) |
Injection site erythema | 37 (33.6) |
Nodules | 14 (12.7) |
Lipoatrophy | 8 (7.3) |
Injection site pain | 7 (6.4) |
Liver function test abnormal | 6 (5.5) |
Leukopenia | 4 (3.6) |
Depression | 2 (1.8) |
Abscess | 2 (1.8) |
Skin rash | 1 (0.9) |
Urticaria | 1 (0.9) |
Note: Percentages are based on the total number of patients (n=110).